The Safety of Ramadan Fasting in Chronic Heart Failure Patients With Reduced Ejection Fraction.

Ahmed F Alaarag, Mahmoud A Elkhalek Abou-Omar, Osama A Amin
Author Information
  1. Ahmed F Alaarag: Department of Cardiology, Tanta University, Egypt.
  2. Mahmoud A Elkhalek Abou-Omar: Department of Cardiology, Tanta University, Egypt.
  3. Osama A Amin: Department of Cardiology, Beni-Suef University, Egypt.

Abstract

Objectives: Even though Islam excludes the sick from Ramadan Fasting (RF), countless Muslims choose to fast throughout this holy month. So, it is of paramount importance to review how RF influences patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF). Our study intended to check the safety of RF in these patients.
Methods: We selected patients under 75 years old with compensated chronic HFrEF. After applying all the exclusion conditions, those who insisted on fasting during the coming Ramadan were enrolled in fasting Group I (90 patients). Those who decided not to fast were listed as control Group II (68 patients) to ensure a comprehensive model.
Results: patients with prior revascularization, AF, lower e-GFR, and poor functional capacity (higher NYHA class) had higher AEs after RF with P values (0.013, 0.027, 0.001, and 0.038), respectively. The low e-GFR and prior revascularization were independent predictors of AEs with P-values (0.005 & 0.031), respectively. The e-GFR (50 ml/min/1.73 m) was cut off at which the incidence of AEs increased, with a specificity and sensitivity of 65 % and 81 %, respectively.
Conclusions: RF may be harmless in low-risk patients with chronic HFrEF under the supervision of a medical professional. However, HFrEF patients with prior coronary revascularization or CKD may have a higher incidence of AEs.

Keywords

References

  1. Nutr J. 2012 Sep 10;11:69 [PMID: 22963582]
  2. Eur Heart J. 2021 Jan 1;42(1):6-7 [PMID: 33180902]
  3. Saudi Med J. 2018 Apr;39(4):395-400 [PMID: 29619492]
  4. Compr Physiol. 2018 Sep 14;8(4):1639-1667 [PMID: 30215867]
  5. Can J Cardiol. 2024 Aug;40(8):1445-1457 [PMID: 38354947]
  6. Diabetes Res Clin Pract. 2020 Nov;169:108465 [PMID: 32971151]
  7. J Mol Cell Cardiol. 2012 Feb;52(2):454-63 [PMID: 21978629]
  8. J Electrocardiol. 2020 Jan - Feb;58:125-127 [PMID: 31838312]
  9. Circ Heart Fail. 2024 May;17(5):e010936 [PMID: 38695175]
  10. Heart. 2022 Feb;108(4):258-265 [PMID: 33990414]
  11. Blood Press Monit. 2020 Aug;25(4):195-200 [PMID: 32404600]
  12. BMC Cardiovasc Disord. 2020 Nov 19;20(1):489 [PMID: 33213367]
  13. JACC Basic Transl Sci. 2023 Feb 20;8(3):239-254 [PMID: 37034280]
  14. Cell Metab. 2023 Jun 6;35(6):928-942.e4 [PMID: 36868222]
  15. Circulation. 2019 Jul 9;140(2):e125-e151 [PMID: 30686041]
  16. Int J Cardiol. 2004 Aug;96(2):217-21 [PMID: 15262036]
  17. Saudi Med J. 2004 Jan;25(1):47-51 [PMID: 14758379]
  18. Int J Nephrol Renovasc Dis. 2015 Jun 01;8:53-7 [PMID: 26082658]

Word Cloud

Created with Highcharts 10.0.0patients0RFRamadanHFrEFAEsFastingchronicHeartEjectionfastingpriorrevascularizatione-GFRhigherrespectivelyfastFailureFractionGroupPatientsincidence%mayObjectives:EventhoughIslamexcludessickcountlessMuslimschoosethroughoutholymonthparamountimportancereviewinfluencesreducedstudyintendedchecksafetyMethods:selected75yearsoldcompensatedapplyingexclusionconditionsinsistedcomingenrolled90decidedlistedcontrolII68ensurecomprehensivemodelResults:AFlowerpoorfunctionalcapacityNYHAclassPvalues013027001038lowindependentpredictorsP-values005&03150ml/min/173mcutincreasedspecificitysensitivity6581Conclusions:harmlesslow-risksupervisionmedicalprofessionalHowevercoronaryCKDSafetyChronicReducedfractionfailureIntermittent

Similar Articles

Cited By (1)